Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors
- PMID: 1382830
- DOI: 10.1002/1097-0142(19921101)70:9<2313::aid-cncr2820700917>3.0.co;2-t
Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors
Abstract
Multiple independent tumors were identified in specimens from 117 of 234 prostatectomies for clinical adenocarcinoma; there were 266 incidental cancers in these 117 prostates. The clinically detected carcinoma was the largest (or only) tumor in all 202 Stage B cases. However, among 32 Stage A cases (detection by transurethral resection), there were 8 prostates in which an incidental tumor was larger than the clinically manifest cancer. These were all small tumors except for two incidental cancers with a volume greater than 2cm3; roughly 80% of incidental carcinomas were smaller than 0.5 cm3, whereas fewer than 20% of manifest tumors were smaller than 0.5 cm3. Comparison with a series of cancers found incidentally at cystoprostatectomy for bladder cancer showed the same volume distribution as incidental (smaller) carcinomas in patients with prostate cancer. This distribution was thought to reflect the volume distribution of prostate cancer in the general population older than 50 years of age. It was concluded that additional incidental tumors are common in patients with prostate cancer, but their sum of volumes is seldom as large as the clinical cancer volume.
Similar articles
-
Incidental Prostate Adenocarcinoma in Cystoprostatectomy Specimens: Partial Versus Complete Prostate Sampling.Int J Surg Pathol. 2017 Aug;25(5):414-420. doi: 10.1177/1066896917696745. Epub 2017 Mar 22. Int J Surg Pathol. 2017. PMID: 28381150
-
The prognostic impact of incidental prostate cancer following radical cystoprostatectomy: a nationwide analysis.Scand J Urol. 2018 Oct-Dec;52(5-6):358-363. doi: 10.1080/21681805.2018.1534885. Epub 2019 Jan 9. Scand J Urol. 2018. PMID: 30624125
-
Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer.Eur Urol. 1996;30(3):322-6. doi: 10.1159/000474190. Eur Urol. 1996. PMID: 8931964
-
Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-Analysis of 13,140 Patients.J Urol. 2017 Feb;197(2):385-390. doi: 10.1016/j.juro.2016.08.088. Epub 2016 Aug 26. J Urol. 2017. PMID: 27569436
-
Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience.Diagn Interv Radiol. 2018 Sep;24(5):316-320. doi: 10.5152/dir.2018.18102. Diagn Interv Radiol. 2018. PMID: 30211685 Free PMC article. Review.
Cited by
-
Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma.J Urol. 2008 Jun;179(6):2203-6; discussion 2206. doi: 10.1016/j.juro.2008.01.114. Epub 2008 Apr 18. J Urol. 2008. PMID: 18423736 Free PMC article.
-
An update on focal therapy for prostate cancer.Nat Rev Urol. 2016 Nov;13(11):641-653. doi: 10.1038/nrurol.2016.177. Epub 2016 Sep 27. Nat Rev Urol. 2016. PMID: 27670618 Review.
-
Focal laser ablation of prostate cancer: numerical simulation of temperature and damage distribution.Biomed Eng Online. 2011 Jun 2;10:45. doi: 10.1186/1475-925X-10-45. Biomed Eng Online. 2011. PMID: 21635775 Free PMC article.
-
Clonal origin and spread of metastatic prostate cancer.Endocr Relat Cancer. 2016 Apr;23(4):R207-17. doi: 10.1530/ERC-16-0049. Epub 2016 Mar 21. Endocr Relat Cancer. 2016. PMID: 27000662 Free PMC article. Review.
-
SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.J Clin Invest. 2018 Jan 2;128(1):381-386. doi: 10.1172/JCI96551. Epub 2017 Dec 4. J Clin Invest. 2018. PMID: 29202479 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical